Volume 7,Issue 1
Analysis of the Impact of TCM Syndrome Differentiation on the Treatment of Hypertensive and Cerebrovascular Diseases
Objective: To explore the effect of TCM syndrome differentiation on the treatment of hypertensive and cerebrovascular diseases. Methods: 80 patients with hypertensive cerebrovascular disease were selected as subjects and randomly divided into a control group (n = 40, treated with Nao’an Capsules) and an observation group (n = 40, treated with TCM syndrome differentiation based on Nao’an Capsules). The clinical efficacy, blood pressure, blood lipid levels, cerebral blood flow, and cerebrovascular function scores of the two groups were evaluated. Results: The clinical efficacy of the observation group was better than that of the control group, P < 0.05. The blood pressure and blood lipid levels of the observation group were lower than those of the control group, P < 0.05. The cerebral blood flow and cerebrovascular function scores of the observation group were better than those of the control group, P < 0.05. Conclusion: The effect of TCM syndrome differentiation treatment on patients with hypertensive and cerebrovascular disease is significant.
[1] Ren WQ, Fan JR, Zhang GY, et al., 2022, Clinical Characteristics and Distribution of TCM Syndrome Factors in Patients with Hypertension Treated with Sangqi Qingxuan Granules. China Medical Herald, 19(32): 117–121.
[2] Lv ZM, 2021, The Efficacy of Traditional Chinese Medicine Syndrome Differentiation in the Treatment of H-Type Hypertension Combined with Vascular Dementia. Electronic Journal of Cardiovascular Diseases of Integrated Traditional Chinese and Western Medicine, 9(20): 68–71.
[3] Han HH, Qiu YY, Xing XP, et al., 2023, How Traditional Chinese Medicine Can Prevent and Treat Hypertension from the “National Guidelines for the Prevention and Treatment of Hypertension at Primary Levels 2020 Edition”. Clinical Research in Traditional Chinese Medicine, 15(09): 1–4.
[4] Wen XH, 2021, Effects of Buyang Huanwu Decoction Combined with Piracetam on Cerebrovascular Function and Oxidative Stress in Patients in the Recovery Period of Hypertensive Cerebral Hemorrhage. Journal of Rational Clinical Medication, 14(12): 145–147.
[5] Xu Q, 2023, Research on the Distribution Patterns of Traditional Chinese Medicine Syndrome Types of Essential Hypertension and Their Correlation with Risk Factors, thesis, Anhui University of Traditional Chinese Medicine.
[6] Wen AM, 2022, Clinical Efficacy of Ginkgo Leaf Extract Combined with Tianma Gouteng Decoction in the Treatment of Patients with Ischemic Cerebrovascular Disease and Hypertension. Journal of Rational Clinical Drug Use, 15(06): 47–50.
[7] Tan W, Liu PY, Lin L, et al., 2019, Research on the Adaptive Regulation Function of Cerebral Blood Vessels in Spontaneously Hypertensive Rats with Yiqi Huatan Recipe. New Chinese Medicine, 51(07): 10–13.
[8] Wu QD, Yan XH, Wu D, et al., 2023, Characteristics of Cognitive Impairment in Hypertension Combined with Cerebral Microbleeds and Analysis of TCM Syndrome Types. Chinese Clinical Research, 36(03): 334–338.
[9] Dong XM, 2019, Randomized Parallel Controlled Study of Syndrome Differentiation and Treatment of Cardiovascular and Cerebrovascular Diseases in the Elderly. Journal of Practical Traditional Chinese Medicine, 33(01): 20–22 + 62.
[10] Yan SJ, 2020, Discussion on the Effect of TCM Syndrome Differentiation Treatment on Elderly Patients with Hypertension. Contemporary Medical Discussions, 18(06): 185–186.